Changes in Beneficial Ownership · 4
Niki BioSolutions, Inc.
NIKINASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-07-22
- Issuer
- Niki BioSolutions, Inc.
- Issuer CIK
- 0001734005
- Trading symbol
- NIKI
Reporting owner 1
- Name
- Sheinerman Kira
- Reporting owner CIK
- 0001438091
- Relationship
- Director · 10% owner
- Address
- 116 VILLAGE BOULEVARD, SUITE 200, PRINCETON, NJ, 08540
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | 8.83 | 2026-07-22 | A · Form 4 | 8,000 | A | 0 | [F1] | 2036-07-22 | Common Stock | 8,000 | 8,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger.↩ 1
Signature 1
- Signed
- /s/ Kira S. Sheinerman
- Date
- 2026-10-21
Company context
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. For more information, please visit the company’s website at www.aptorumgroup.com.